• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

An ongoing study of anemia correction in chronic kidney disease.

作者信息

Pfeffer Marc A

出版信息

N Engl J Med. 2007 Mar 1;356(9):959-61. doi: 10.1056/NEJMc066568.

DOI:10.1056/NEJMc066568
PMID:17329707
Abstract
摘要

相似文献

1
An ongoing study of anemia correction in chronic kidney disease.一项正在进行的慢性肾脏病贫血纠正研究。
N Engl J Med. 2007 Mar 1;356(9):959-61. doi: 10.1056/NEJMc066568.
2
Chronic kidney disease anemia management: what should be done?慢性肾脏病贫血管理：应该怎么做？
Blood Purif. 2011;31(1-3):186-8. doi: 10.1159/000321852. Epub 2011 Jan 10.
3
Darbepoetin alfa and chronic kidney disease.达比泊汀α与慢性肾脏病
N Engl J Med. 2010 Feb 18;362(7):654; author reply 655.
4
Anemia management in chronic kidney disease: bursting the hemoglobin bubble.慢性肾脏病的贫血管理：打破血红蛋白的泡影
Ann Intern Med. 2010 Jul 6;153(1):53-5. doi: 10.7326/0003-4819-153-1-201007060-00250. Epub 2010 May 3.
5
Treatment of anemia in chronic kidney disease--strategies based on evidence.慢性肾脏病贫血的治疗——基于证据的策略
N Engl J Med. 2009 Nov 19;361(21):2089-90. doi: 10.1056/NEJMe0909664. Epub 2009 Oct 30.
6
Erythropoiesis-stimulating agents--time for a reevaluation.促红细胞生成素——是时候重新评估了。
N Engl J Med. 2010 Jan 21;362(3):189-92. doi: 10.1056/NEJMp0912328. Epub 2010 Jan 6.
7
Darbepoetin alfa and chronic kidney disease.阿法达贝泊汀与慢性肾脏病
N Engl J Med. 2010 Feb 18;362(7):653; author reply 655. doi: 10.1056/NEJMc0912452.
8
Darbepoetin alfa and chronic kidney disease.达贝泊汀α与慢性肾脏病
N Engl J Med. 2010 Feb 18;362(7):654-5; author reply 655.
9
Does TREAT give the boot to ESAs in the treatment of CKD anemia?在慢性肾脏病贫血的治疗中，TREAT是否会淘汰促红细胞生成素类药物？
J Am Soc Nephrol. 2010 Jan;21(1):2-6. doi: 10.1681/ASN.2009111127. Epub 2009 Dec 24.
10
Emerging drugs for treatment of anemia of chronic kidney disease.新兴药物治疗慢性肾脏病相关性贫血。
Expert Opin Emerg Drugs. 2013 Dec;18(4):421-9. doi: 10.1517/14728214.2013.836490. Epub 2013 Sep 16.

引用本文的文献

1
Interventions for fatigue in people with kidney failure requiring dialysis.肾衰竭需透析患者的疲劳干预措施。
Cochrane Database Syst Rev. 2023 Aug 31;8(8):CD013074. doi: 10.1002/14651858.CD013074.pub2.
2
Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis.促红细胞生成素刺激剂治疗慢性肾脏病成人贫血的网状 Meta 分析。
Cochrane Database Syst Rev. 2023 Feb 13;2(2):CD010590. doi: 10.1002/14651858.CD010590.pub3.
3
Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis.
促红细胞生成素用于治疗成人慢性肾脏病贫血：一项网状Meta分析
Cochrane Database Syst Rev. 2014 Dec 8;2014(12):CD010590. doi: 10.1002/14651858.CD010590.pub2.
4
Darbepoetin for the anaemia of chronic kidney disease.达贝泊汀用于治疗慢性肾脏病贫血
Cochrane Database Syst Rev. 2014 Mar 31;2014(3):CD009297. doi: 10.1002/14651858.CD009297.pub2.
5
Use of agents stimulating erythropoiesis in digestive diseases.促红细胞生成剂在消化系统疾病中的应用。
World J Gastroenterol. 2009 Oct 7;15(37):4675-85. doi: 10.3748/wjg.15.4675.
6
Maintaining high hemoglobin levels improved the left ventricular mass index and quality of life scores in pre-dialysis Japanese chronic kidney disease patients.维持较高的血红蛋白水平可改善日本透析前慢性肾脏病患者的左心室质量指数和生活质量评分。
Clin Exp Nephrol. 2010 Feb;14(1):28-35. doi: 10.1007/s10157-009-0212-4. Epub 2009 Sep 9.
7
The correction of anemia in patients with the combination of chronic kidney disease and congestive heart failure may prevent progression of both conditions.慢性肾脏病合并充血性心力衰竭患者贫血的纠正可能会阻止这两种疾病的进展。
Clin Exp Nephrol. 2009 Apr;13(2):101-106. doi: 10.1007/s10157-008-0074-1. Epub 2008 Aug 1.
8
The role of anemia management in improving outcomes for African-Americans with chronic kidney disease.贫血管理在改善非裔美国慢性肾病患者预后方面的作用。
Am J Nephrol. 2008;28(5):732-43. doi: 10.1159/000127981. Epub 2008 Apr 24.
9
Anemia treatment in chronic kidney disease: shifting uncertainty.
Heart Fail Rev. 2008 Dec;13(4):425-30. doi: 10.1007/s10741-008-9087-9. Epub 2008 Apr 10.
10
Recombinant human Epo treatment: beneficial in chronic kidney disease, chronic heart failure, or both? Editorial to: "Correction of anemia with erythropoietin in chronic kidney disease (stage 3 or 4): effects on cardiac performance by Pappas et al.".重组人促红细胞生成素治疗：对慢性肾脏病、慢性心力衰竭或两者均有益？对《帕帕斯等人：促红细胞生成素纠正慢性肾脏病（3或4期）贫血对心脏功能的影响》一文的编者按
Cardiovasc Drugs Ther. 2008 Feb;22(1):1-2. doi: 10.1007/s10557-008-6079-x.